vs
Side-by-side financial comparison of PROSPERITY BANCSHARES INC (PB) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.
PROSPERITY BANCSHARES INC is the larger business by last-quarter revenue ($367.6M vs $209.6M, roughly 1.8× Varex Imaging Corp). PROSPERITY BANCSHARES INC runs the higher net margin — 31.6% vs 1.1%, a 30.5% gap on every dollar of revenue. Over the past eight quarters, PROSPERITY BANCSHARES INC's revenue compounded faster (19.2% CAGR vs 0.8%).
Prosperity Bancshares, Inc. is a bank holding company headquartered in Houston, Texas with operations in Texas and central Oklahoma. As of December 31, 2019, the company operated 285 branches: 65 in the Houston area, including The Woodlands, Texas; 30 in South Texas, including Corpus Christi, Texas and Victoria, Texas; 75 in the Dallas–Fort Worth metroplex; 22 in East Texas; 29 in Central Texas, including Austin, Texas and San Antonio; 34 in West Texas, including Lubbock, Texas, Midland–Odess...
Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.
PB vs VREX — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $367.6M | $209.6M |
| Net Profit | $116.3M | $2.3M |
| Gross Margin | — | 33.3% |
| Operating Margin | — | 7.3% |
| Net Margin | 31.6% | 1.1% |
| Revenue YoY | — | 4.9% |
| Net Profit YoY | -10.7% | 866.7% |
| EPS (diluted) | $1.16 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $367.6M | $209.6M | ||
| Q4 25 | $275.0M | $228.9M | ||
| Q3 25 | $273.4M | $203.0M | ||
| Q2 25 | $267.7M | $212.9M | ||
| Q1 25 | $265.4M | $199.8M | ||
| Q4 24 | $267.8M | — | ||
| Q3 24 | $261.7M | $205.7M | ||
| Q2 24 | $258.8M | $209.1M |
| Q1 26 | $116.3M | $2.3M | ||
| Q4 25 | $139.9M | $12.2M | ||
| Q3 25 | $137.6M | $-89.1M | ||
| Q2 25 | $135.2M | $6.9M | ||
| Q1 25 | $130.2M | $-300.0K | ||
| Q4 24 | $130.1M | — | ||
| Q3 24 | $127.3M | $-51.1M | ||
| Q2 24 | $111.6M | $1.4M |
| Q1 26 | — | 33.3% | ||
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 36.0% | ||
| Q1 25 | — | 34.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 32.6% | ||
| Q2 24 | — | 32.0% |
| Q1 26 | — | 7.3% | ||
| Q4 25 | 65.1% | 8.6% | ||
| Q3 25 | 64.4% | -39.8% | ||
| Q2 25 | 64.3% | 10.4% | ||
| Q1 25 | 62.7% | 5.6% | ||
| Q4 24 | 62.0% | — | ||
| Q3 24 | 62.1% | 5.3% | ||
| Q2 24 | 55.2% | 4.4% |
| Q1 26 | 31.6% | 1.1% | ||
| Q4 25 | 50.9% | 5.3% | ||
| Q3 25 | 50.3% | -43.9% | ||
| Q2 25 | 50.5% | 3.2% | ||
| Q1 25 | 49.1% | -0.2% | ||
| Q4 24 | 48.6% | — | ||
| Q3 24 | 48.6% | -24.8% | ||
| Q2 24 | 43.1% | 0.7% |
| Q1 26 | $1.16 | $0.05 | ||
| Q4 25 | $1.48 | $0.29 | ||
| Q3 25 | $1.45 | $-2.15 | ||
| Q2 25 | $1.42 | $0.17 | ||
| Q1 25 | $1.37 | $-0.01 | ||
| Q4 24 | $1.36 | — | ||
| Q3 24 | $1.34 | $-1.25 | ||
| Q2 24 | $1.17 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $125.6M |
| Total DebtLower is stronger | — | $367.6M |
| Stockholders' EquityBook value | $8.2B | $476.9M |
| Total Assets | $43.6B | $1.1B |
| Debt / EquityLower = less leverage | — | 0.77× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $125.6M | ||
| Q4 25 | — | $155.1M | ||
| Q3 25 | — | $152.6M | ||
| Q2 25 | — | $223.0M | ||
| Q1 25 | — | $212.6M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $200.5M | ||
| Q2 24 | — | $190.0M |
| Q1 26 | — | $367.6M | ||
| Q4 25 | — | $367.5M | ||
| Q3 25 | — | $367.5M | ||
| Q2 25 | — | $567.2M | ||
| Q1 25 | — | $567.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $443.4M | ||
| Q2 24 | — | $443.1M |
| Q1 26 | $8.2B | $476.9M | ||
| Q4 25 | $7.6B | $472.6M | ||
| Q3 25 | $7.7B | $455.3M | ||
| Q2 25 | $7.6B | $549.7M | ||
| Q1 25 | $7.5B | $540.2M | ||
| Q4 24 | $7.4B | — | ||
| Q3 24 | $7.4B | $529.1M | ||
| Q2 24 | $7.3B | $581.2M |
| Q1 26 | $43.6B | $1.1B | ||
| Q4 25 | $38.5B | $1.1B | ||
| Q3 25 | $38.3B | $1.1B | ||
| Q2 25 | $38.4B | $1.4B | ||
| Q1 25 | $38.8B | $1.3B | ||
| Q4 24 | $39.6B | — | ||
| Q3 24 | $40.1B | $1.2B | ||
| Q2 24 | $39.8B | $1.3B |
| Q1 26 | — | 0.77× | ||
| Q4 25 | — | 0.78× | ||
| Q3 25 | — | 0.81× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-16.1M |
| Free Cash FlowOCF − Capex | — | $-26.8M |
| FCF MarginFCF / Revenue | — | -12.8% |
| Capex IntensityCapex / Revenue | — | 5.1% |
| Cash ConversionOCF / Net Profit | — | -7.00× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-16.1M | ||
| Q4 25 | $78.3M | $7.9M | ||
| Q3 25 | $194.8M | $7.7M | ||
| Q2 25 | $98.2M | $16.6M | ||
| Q1 25 | $178.2M | $9.5M | ||
| Q4 24 | $-205.8M | — | ||
| Q3 24 | $274.6M | $25.9M | ||
| Q2 24 | $216.5M | $8.0M |
| Q1 26 | — | $-26.8M | ||
| Q4 25 | $68.5M | $2.3M | ||
| Q3 25 | $185.7M | $1.4M | ||
| Q2 25 | $91.8M | $9.8M | ||
| Q1 25 | $171.1M | $5.3M | ||
| Q4 24 | $-210.7M | — | ||
| Q3 24 | $270.2M | $19.9M | ||
| Q2 24 | $211.8M | $3.3M |
| Q1 26 | — | -12.8% | ||
| Q4 25 | 24.9% | 1.0% | ||
| Q3 25 | 67.9% | 0.7% | ||
| Q2 25 | 34.3% | 4.6% | ||
| Q1 25 | 64.5% | 2.7% | ||
| Q4 24 | -78.7% | — | ||
| Q3 24 | 103.3% | 9.7% | ||
| Q2 24 | 81.8% | 1.6% |
| Q1 26 | — | 5.1% | ||
| Q4 25 | 3.6% | 2.4% | ||
| Q3 25 | 3.3% | 3.1% | ||
| Q2 25 | 2.4% | 3.2% | ||
| Q1 25 | 2.7% | 2.1% | ||
| Q4 24 | 1.8% | — | ||
| Q3 24 | 1.7% | 2.9% | ||
| Q2 24 | 1.8% | 2.2% |
| Q1 26 | — | -7.00× | ||
| Q4 25 | 0.56× | 0.65× | ||
| Q3 25 | 1.42× | — | ||
| Q2 25 | 0.73× | 2.41× | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | -1.58× | — | ||
| Q3 24 | 2.16× | — | ||
| Q2 24 | 1.94× | 5.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PB
| Net Interest Income | $321.1M | 87% |
| Noninterest Income | $46.5M | 13% |
VREX
| Medical Segment | $144.8M | 69% |
| Industrial Segment | $64.8M | 31% |
